Existing research results have indicated that ER- and PR- breast cancers tend to a worse prognosis than ER+ or PR+ breast cancers, while ER+ and PR+ tumors are well differentiated and less aggressive to a large extent (30). This evidence concerns the gene PGR and breast carcinoma.